Progression of Metastatic Pancreatic Cancer

5 Mga view
administrator
administrator
07/30/23

George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

  • Kategorya

Magpakita ng higit pa

0 Mga komento Pagbukud-bukurin Ayon

Walang nakitang komento

Mga Komento sa Facebook

Susunod